title: Norm- and hypo-fractionated radiotherapy is capable of activating human dendritic cells.
abstract: Despite the transient immunosuppressive properties of local radiotherapy (RT), this classical treatment modality of solid tumors is capable of inducing immunostimulatory forms of tumor-cell death. The resulting 'immunotoxicity' in the tumor, but not in healthy tissues, may finally lead to immune-mediated destruction of the tumor. However, little is known about the best irradiation scheme in this setting. This study examines the immunological effects of differently irradiated human colorectal tumor cells on human monocyte-derived dendritic cells (DC). Human SW480 tumor cells were irradiated with a norm-fractionation scheme (5 × 2 Gy), a hypo-fractionated protocol (3 × 5 Gy), and with a high single irradiation dose (radiosurgery; 1 × 15 Gy). Subsequently, human immature DC (iDC) were co-incubated with supernatants (SN) of these differently treated tumor cells. Afterwards, DC were analyzed regarding the expression of maturation markers, the release of cytokines, and the potential to stimulate CD4(+) T-cells. The co-incubation of iDC with SN of tumor cells exposed to norm- or hypo-fractionated RT resulted in a significantly increased secretion of the immune activating cytokines IL-12p70, IL-8, IL-6, and TNFα, compared to iDC co-incubated with SN of tumor cells that received a high single irradiation dose or were not irradiated. In addition, DC-maturation markers CD80, CD83, and CD25 were also exclusively elevated after co-incubation with the SN of fractionated irradiated tumor cells. Furthermore, the SN of tumor cells that were irradiated with norm- or hypo-fractionated RT triggered iDC to stimulate CD4(+) T-cells not only in an allogenic, but also in an antigen-specific manner like mature DC. Collectively, these results demonstrate that norm- and hypo-fractionated RT induces a fast human colorectal tumor-cell death with immunogenic potential that can trigger DC maturation and activation in vitro. Such findings may contribute to the improvement of irradiation protocols for the most beneficial induction of anti-tumor immunity.
authors: Department of Radiation Oncology .
authors: Lorenz
authors: L
authors: Kulzer
authors: Yvonne
authors: Y
authors: Rubner
authors: Lisa
authors: L
authors: Deloch
authors: Andrea
authors: A
authors: Allgäuer
authors: Benjamin
authors: B
authors: Frey
authors: Rainer
authors: R
authors: Fietkau
authors: Jan
authors: J
authors: Dörrie
authors: Niels
authors: N
authors: Schaft
authors: Udo S
authors: US
authors: Gaipl
mesh_terms: D015703:Antigens, CD / Q000378:metabolism; D024221:Antineoplastic Protocols; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D016923:Cell Death; D002454:Cell Differentiation; D045744:Cell Line, Tumor; D015179:Colorectal Neoplasms / Q000276:immunology / Q000532:radiotherapy*; D016207:Cytokines / Q000378:metabolism; D003713:Dendritic Cells / Q000276:immunology* / Q000528:radiation effects*; D019583:Dose Fractionation, Radiation; D006801:Humans; D008213:Lymphocyte Activation; D019899:Paracrine Communication
chemical_list: D015703:Antigens, CD; D016207:Cytokines
keywords: Dendritic cells; T-cell activation; human colorectal tumor cells; hypo-fractionated radiotherapy; immunogenic cell death; immunotherapy; ionizing irradiation; norm-fractionated radiotherapy